Covid-19: clinical trials using Covaxin on children begins
Jun 11, 2021, at 02:38 am
Bengaluru/UNI: In all 30 children, aged 12-18, were administered Covaxin at Mysuru Medical College and Research Institute (MMCRI) as part of Hyderabad-based pharmaceutical major Bharat Biotech's clinical trials.
'Well established' foreign COVID-19 vaccines makers need no bridging clinical trials in India
Jun 02, 2021, at 06:38 pm
New Delhi/IBNS: The Indian government has exempted "well established" foreign COVID-19 vaccines makers from any bridging clinical trials if it has been certified by the National Control Lab of the country where it is made, media reports said.
Indian drug regulator DGCI clears Covaxin phase 2, 3 clinical trials for children
May 13, 2021, at 05:08 pm
New Delhi/IBNS: India's drug regulator body has cleared the second and third phase of clinical trials of indigenous anti-Covid-19 vaccine, Covaxin, for children, media reports said.
Registration for human clinical trial of Covaxin at AIIMS begins
Jul 20, 2020, at 07:23 pm
New Delhi/UNI: Registration for the human clinical trial of indigenously-developed Covid-19 vaccine, Covaxin, started in All India Institute of Medical Sciences (AIIMS) here on Monday.
Glenmark to conduct clinical trials in India for potential COVID-19 drug
Apr 30, 2020, at 04:58 pm
New Delhi/IBNS: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, on Thursday announced that it has received approval from the DCGI (Drug Controller General of India), the regulator in India to conduct clinical trials on Favipiravir Antiviral tablets on COVID-19 patients.
Four clinical trials suggest doctors focus on heart disease, not just glucose, says study
Jul 09, 2017, at 01:03 am
New York, July 8 (IBNS): Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type 2 diabetes management can leave patients at risk for heart attack and stroke. But results from four recent randomized clinical trials suggest that using medications that offer glucose control while reducing the risk for cardiovascular disease could improve patient outcomes.